Center for Scientific Review; Notice of Closed Meetings, 4833 [2019-02612]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 33 / Tuesday, February 19, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
tkelley on DSKBCP9HB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–18–
009: Academic-Industrial Partnerships
Research for Cancer Diagnosis and
Treatment.
Date: March 20, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR:
Selected Topics in Transfusion Medicine.
Date: March 21–22, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9497, zouai@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: International and Cooperative
Projects 1.
Date: March 25, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Brian H. Scott, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
VerDate Sep<11>2014
17:46 Feb 15, 2019
Jkt 247001
Rockledge Drive, Bethesda, MD 20892, 301–
827–7490, brianscott@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and Related Research.
Date: March 28, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shalanda A. Bynum,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
Bethesda, MD 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Vascular
and Hematology AREA Application Review.
Date: April 5, 2019.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Natalia Komissarova,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
MSC 7846, Bethesda, MD 20892, 301–435–
1206, komissar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 12, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–02612 Filed 2–15–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Toxicology Program; Notice
of Public Meeting: Converging on
Cancer Workshop
AGENCY:
National Institutes of Health,
HHS.
Notice of Public Meeting and
Registration Information.
ACTION:
The National Toxicology
Program (NTP) announces a workshop
titled ‘‘Converging on Cancer’’ on April
29–30, 2019, to bring together
researchers working in the area of
cancer biology, assay development,
mixtures toxicology, in silico modeling,
and cancer risk assessment. The
objectives of the workshop are to
identify technologies and models that
can be used in a systems toxicology
SUMMARY:
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
4833
approach for cancer risk assessment.
Specific applications to understanding
the joint effects of multiple chemical
exposures will be discussed. The
workshop will consist of plenary
sessions (webcast), breakout discussion
sessions, and a poster session. This
workshop is open to the public.
Members of the public can register to
attend the workshop in person as
observers or view the plenary
proceedings via webcast.
DATES:
Meeting: April 29–30, 2019, begins at
9:00 a.m. to approximately 5:00 p.m.
Eastern Daylight Time (EDT).
Meeting Registration: Deadline is
April 22, 2019. Registration to view the
workshop via webcast is required.
ADDRESSES:
Meeting Location: William J. Clinton
East Building, U.S. Environmental
Protection Agency, 1201 Constitution
Ave. NW, Washington, DC 20460.
Meeting Web page: The preliminary
agenda and registration are at https://
ntp.niehs.nih.gov/go/coc.
Webcast: Plenary sessions of the
workshop will be webcast; the URL will
be provided to those who register for
viewing.
FOR FURTHER INFORMATION CONTACT: Dr.
Cynthia Rider, Toxicology Branch,
NIEHS, P.O. Box 12233, K2–12,
Research Triangle Park, NC 27709,
(telephone) 984–287–3175, Email:
cynthia.rider@nih.gov.
SUPPLEMENTARY INFORMATION:
Background: Cancer is a leading cause
of mortality worldwide. While the
defining feature of cancer is
uncontrolled division of abnormal cells,
it is a complex disease with varied
presentations (i.e., different etiologies
and target tissues) that involves
dysregulation of multiple
interconnected signaling pathways.
Diverse environmental factors have been
associated with the development and
progression of various cancer types. A
critical question in the field of
environmental health is how to harness
what is known about cancer biology and
associated environmental exposures to
improve public health outcomes. The
Converging on Cancer Workshop is
aimed at providing a clear path forward
for evaluating the interactions between
environmental exposures and cancer
biology using the latest tools in
toxicology and identifying knowledge
gaps that require research attention.
Potential applications of this
understanding include building a
framework for incorporating
mechanistic data into cancer risk
assessment, developing effective
screening tools to detect the
E:\FR\FM\19FEN1.SGM
19FEN1
]]>Agencies
[Federal Register Volume 84, Number 33 (Tuesday, February 19, 2019)]
[Notices]
[Page 4833]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02612]
[[Page 4833]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-18-009: Academic-Industrial Partnerships Research for
Cancer Diagnosis and Treatment.
Date: March 20, 2019.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, 301-237-
9870, xuguofen@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR: Selected Topics in Transfusion Medicine.
Date: March 21-22, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD
20892, 301-408-9497, zouai@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: International and Cooperative Projects 1.
Date: March 25, 2019.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Brian H. Scott, Ph.D., Scientific Review
Officer, National Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301-827-7490,
brianscott@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: AIDS and Related Research.
Date: March 28, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shalanda A. Bynum, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 301-
755-4355, bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Vascular and Hematology AREA Application Review.
Date: April 5, 2019.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Natalia Komissarova, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207, MSC 7846, Bethesda, MD
20892, 301-435-1206, komissar@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 12, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-02612 Filed 2-15-19; 8:45 am]
BILLING CODE 4140-01-P
